OCT 21, 2021 9:31 AM PDT

Cholesterol Drug Regrows Neurons After Spinal Cord Injury

WRITTEN BY: Annie Lennon

Fenofibrate, an FDA-approved drug used to reduce cholesterol levels, causes sensory neurons in the spine following spinal cord injury to regrow twice as fast as with a placebo treatment. The results were published in eLife.

Following a spinal cord injury, several lines of communication between the body and brain may be damaged. Damage to the motor and sensory neurons in the central nervous system is often unable to completely heal and thus can leave survivors with chronic paralysis, numbness, and pain. 

While neurons in the brain and spinal cord (the central nervous system) have limited ability to heal after injury, those in the periphery areas of the body, such as the arms and legs, heal quickly after damage- explaining why after getting a cut on your arms or legs, you do not go permanently numb. 

The researchers behind the present study suspected that the difference between healing in the central nervous system and the peripheral nervous system might lie in different responses to the injury among support cells- cells that surround neurons and protect and nurture them. 

From various experiments, they found that a set of genes known as the PPAR-alpha pathway- known its role in fat metabolism- became highly expressed following injury to peripheral axon branches, but not following injury to central axonal branches. They found that PPAR-alpha expression was, in fact, inhibited after spinal cord injury in the central nervous system. 

The researchers thus suspected that the PPAR-alpha pathway might promote the regrowth of sensory neurons. They thus fed mice fenofibrate- a drug that activates the PPAR-alpha pathway- for two weeks before injuring their sensory axon branch that leads to the central nervous system. 

Three days later, they found that mice fed fenofibrate experienced twice the regrowth of sensory neurons as those who had received a placebo. 

“PPAR alpha is only expressed in satellite glial cells, not in neurons, so these results tell us that targeting these support cells can improve regeneration and potentially relieve sensory symptoms like pain,” said senior author Valeria Cavalli, PhD, senior author of the paper. 

“It gives us an additional tool to design therapies to restore function after nerve injuries. We haven’t fixed spinal cord injury, but we’re one step closer to figuring out how to do it," she added. 

In future research, the scientists plan on enhancing neuronal regrowth by combining fenofibrate with other experimental regeneration therapies that target neurons or other aspects of the central nervous system. 

 

Sources: eLifeNeuroscience News

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
MAR 18, 2022
Drug Discovery & Development
In drug development studies, sleep is an important and overlooked vital sign
MAR 18, 2022
In drug development studies, sleep is an important and overlooked vital sign
Today is World Sleep Day, a celebration of sleep that aims to bring awareness to the importance of sleep as a found ...
MAR 23, 2022
Immunology
Drug That Reverses Immune Aging Can Prevent COVID-19 Death
MAR 23, 2022
Drug That Reverses Immune Aging Can Prevent COVID-19 Death
As we age, parts of our bodies get old and worn out, including the immune system. That's one reason why COVID-19 has bee ...
MAR 30, 2022
Drug Discovery & Development
Universal Flu Vaccine Shows Promise in Mice
MAR 30, 2022
Universal Flu Vaccine Shows Promise in Mice
Just one dose of a new vaccine candidate may protect against multiple strains of flu. The corresponding research was pub ...
APR 28, 2022
Immunology
Lipid Supplement May Reduce Inflammation in MS
APR 28, 2022
Lipid Supplement May Reduce Inflammation in MS
Administration of an inflammation-mediating lipid has shown promise in reducing multiple sclerosis-related inflammation ...
MAY 13, 2022
Drug Discovery & Development
Promising New Treatment for Cat Litter Parasite T. Gondii
MAY 13, 2022
Promising New Treatment for Cat Litter Parasite T. Gondii
Researchers have discovered a promising therapy for those suffering from toxoplasmosis, a disease caused by a parasite l ...
MAY 19, 2022
Drug Discovery & Development
Experimental Drug Shows Promise Against ALS
MAY 19, 2022
Experimental Drug Shows Promise Against ALS
A new experimental drug known as NU-9 may be more effective in treating ALS than existing FDA-approved drugs. The corres ...
Loading Comments...